169 related articles for article (PubMed ID: 19376840)
1. Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method.
Cornell KA; Primus S; Martinez JA; Parveen N
J Antimicrob Chemother; 2009 Jun; 63(6):1163-72. PubMed ID: 19376840
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.
Cornell KA; Knippel RJ; Cortright GR; Fonken M; Guerrero C; Hall AR; Mitchell KA; Thurston JH; Erstad P; Tao A; Xu D; Parveen N
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129455. PubMed ID: 31669585
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in
Chakraborti M; Schlachter S; Primus S; Wagner J; Sweet B; Carr Z; Cornell KA; Parveen N
Pathogens; 2020 Aug; 9(9):. PubMed ID: 32825529
[TBL] [Abstract][Full Text] [Related]
4. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
Feng J; Shi W; Zhang S; Zhang Y
Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
[TBL] [Abstract][Full Text] [Related]
5. Methylthioadenosine/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism.
Parveen N; Cornell KA
Mol Microbiol; 2011 Jan; 79(1):7-20. PubMed ID: 21166890
[TBL] [Abstract][Full Text] [Related]
6. Structural comparison of MTA phosphorylase and MTA/AdoHcy nucleosidase explains substrate preferences and identifies regions exploitable for inhibitor design.
Lee JE; Settembre EC; Cornell KA; Riscoe MK; Sufrin JR; Ealick SE; Howell PL
Biochemistry; 2004 May; 43(18):5159-69. PubMed ID: 15122881
[TBL] [Abstract][Full Text] [Related]
7. Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi.
Horowitz RI; Murali K; Gaur G; Freeman PR; Sapi E
BMC Res Notes; 2020 Sep; 13(1):455. PubMed ID: 32993780
[TBL] [Abstract][Full Text] [Related]
8. Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.
Pothineni VR; Wagh D; Babar MM; Inayathullah M; Solow-Cordero D; Kim KM; Samineni AV; Parekh MB; Tayebi L; Rajadas J
Drug Des Devel Ther; 2016; 10():1307-22. PubMed ID: 27103785
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
Caol S; Divers T; Crisman M; Chang YF
BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
Johnson RC; Kodner CB; Jurkovich PJ; Collins JJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2133-6. PubMed ID: 2073103
[TBL] [Abstract][Full Text] [Related]
11. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.
Feng J; Auwaerter PG; Zhang Y
PLoS One; 2015; 10(3):e0117207. PubMed ID: 25806811
[TBL] [Abstract][Full Text] [Related]
12. Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
Pothineni VR; Potula HSK; Ambati A; Mallajosyula VVA; Sridharan B; Inayathullah M; Ahmed MS; Rajadas J
Sci Rep; 2020 Mar; 10(1):3798. PubMed ID: 32123189
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening identifies three inhibitor classes of the telomere resolvase from the lyme disease spirochete.
Lefas G; Chaconas G
Antimicrob Agents Chemother; 2009 Oct; 53(10):4441-9. PubMed ID: 19596868
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of potent "sulfur-free" transition state analogue inhibitors of 5'-methylthioadenosine nucleosidase and 5'-methylthioadenosine phosphorylase.
Longshaw AI; Adanitsch F; Gutierrez JA; Evans GB; Tyler PC; Schramm VL
J Med Chem; 2010 Sep; 53(18):6730-46. PubMed ID: 20718423
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.
Yang X; Nguyen A; Qiu D; Luft BJ
J Antimicrob Chemother; 2009 Apr; 63(4):709-12. PubMed ID: 19182236
[TBL] [Abstract][Full Text] [Related]
16. Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.
Wu X; Sharma B; Niles S; O'Connor K; Schilling R; Matluck N; D'Onofrio A; Hu LT; Lewis K
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126963
[No Abstract] [Full Text] [Related]
17. Structure-based design, synthesis, and antimicrobial activity of purine derived SAH/MTA nucleosidase inhibitors.
Tedder ME; Nie Z; Margosiak S; Chu S; Feher VA; Almassy R; Appelt K; Yager KM
Bioorg Med Chem Lett; 2004 Jun; 14(12):3165-8. PubMed ID: 15149667
[TBL] [Abstract][Full Text] [Related]
18. Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime.
Feng J; Weitner M; Shi W; Zhang S; Zhang Y
Front Microbiol; 2016; 7():62. PubMed ID: 26903956
[TBL] [Abstract][Full Text] [Related]
19. An optimized SYBR Green I/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi.
Feng J; Wang T; Zhang S; Shi W; Zhang Y
PLoS One; 2014; 9(11):e111809. PubMed ID: 25365247
[TBL] [Abstract][Full Text] [Related]
20. Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice.
Parveen N; Cornell KA; Bono JL; Chamberland C; Rosa P; Leong JM
Infect Immun; 2006 May; 74(5):3016-20. PubMed ID: 16622242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
